View experts by name

View by service and office location

Faye Marks

Solicitor

T: 01225 459 981 (DDI)
T: 01225 730 100
E: faye.marks@roydswithyking.com

Faye is a member of our Medical Negligence team, specialising in the areas of birth injury and prescription errors.



Prior to joining Royds Withy King, Faye worked at Lyons Davidson, where she trained and specialised exclusively in Claimant Clinical Negligence work since 2010. I have experience of all areas of Clinical Negligence but I have a particular interest in the following areas:

  • Birth injuries
  • Maternal injuries
  • Drug and prescribing errors
  • Orthopaedic injuries, including amputation
  • General and colorectal surgery
  • Delays in diagnosis

The best part of my job is building strong relationships with my clients and providing invaluable support and advice at one of the most difficult times in their life. I aim to achieve the best possible outcome for my clients and enable them to move on from their experience.

Faye Marks

Related articles

Opinion [4]
Article thumbnail

Lacking clinical evidence and causing injury – the ever-growing case against mesh implants

28 January 2020

A lack of sufficient clinical tests carried out on multiple surgical meshes before they are used to treat hernia patients has caused a new wave of concern amongst healthcare professionals.

Read more..
Article thumbnail

How new funding from the Bill and Melinda Gates Foundation will help ground-breaking research into medication during pregnancy

28 October 2019

Faye Marks looks at new research which is aiming to make medicines safe for pregnant women, which has just received a sizeable grant from the Bill and Melinda Gates Foundation.

Read more..
Article thumbnail

The Medicines and Healthcare products Regulatory Agency issues reminder of the risk of potentially fatal cardiac events associated with cancer drug carfilzomib

24 October 2019

Faye Marks takes a look at the recent reminder from the MHRA of the potentially fatal risks of carfilzomib.

Read more..
Article thumbnail

New measures recommended to avoid potentially fatal overdoses of commonly prescribed rheumatoid arthritis drug

14 October 2019

In August 2019 the European Medicines Agency (EMA) recommended new measures to prevent serious and potentially fatal errors with the dosing of methotrexate, a chemotherapy drug used to treat cancer and autoimmune diseases such as rheumatoid arthritis, psoriasis and Crohn’s disease. Methotrexate is an effective medicine for these conditions, however it can also be highly toxic.

Read more..

View experts by name

View by service and office location